Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I-II Randomized Prospective Double-blind Multi-center Trial on the Effects of a Short Course of Oral Everolimus on Infarct Size, Left Ventricular Remodeling and Inflammation in Patients With Acute ST-Elevation Myocardial Infarction

NCT01529554 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT01529554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01529554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I-II Randomized Prospective Double-blind Multi-center Trial on the Effects of a Short Course of Oral Everolimus on Infarct Size, Left Ventricular Remodeling and Inflammation in Patients With Acute ST-Elevation Myocardial Infarction
Lead sponsor
University of Zurich
Phase
Phase 1/2
Overall status
Completed
Start date
January 8, 2015
Completion date
November 29, 2021
Enrollment
150 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes